N. Piazza is a consultant/proctor for HighLife, Medtronic and MicroPort, and is a consultant for Cephea. The other authors have no conflicts of interest to declare.
NEW ISSUE
The ISCHEMIA trial in real-world practice, a new “uncaging” coronary stent, PCI of the LM trifurcation in the EXCEL trial and more...
December 18, 2020